About Kenan Turnacioglu
Kenan Turnacioglu is a healthcare investor who sits on the boards of Sentonix, Ratio Therapeutics, Immunai and Massive Bio. He was a general partner and investment committee member at Catalio Capital Management, which backs Sentonix, and since 2023 he has been an executive advisor to Ratio Therapeutics. He was also chair of Paige AI.
He co-founded PointState Capital in 2011 and stayed until 2018. Earlier he managed healthcare investments at Duquesne Capital Management from 2001 to 2010 and was a biotechnology research analyst at Credit Suisse from 1998 to 2000. His past board seats include StemCentrx from 2013 to 2016, Agensys from 2004 to 2007 and the NYU Langone Cancer Center from 2010 to 2015. He has also served on the boards of Nammi Therapeutics and AbbraTech.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Kenan Turnacioglu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kenan Turnacioglu works with at each company, as listed on that company's latest Form D.
